BIOMAT Database Logo BIOMAT Database Logo

[Evaluation of the effectiveness of massive vaccination against influenza]. 1966

A N Slepushkin, and T K Bobyleva, and A E Russina, and B S Vitkina, and N S Ellengorn

UI MeSH Term Description Entries
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D007252 Influenza Vaccines Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains. Flu Vaccine,Influenzavirus Vaccine,Monovalent Influenza Vaccine,Universal Flu Vaccine,Universal Influenza Vaccine,Flu Vaccines,High-Dose Trivalent Influenza Vaccine,Influenza Vaccine,Influenza Virus Vaccine,Influenza Virus Vaccines,Influenzavirus Vaccines,Intranasal Live-Attenuated Influenza Vaccine,LAIV Vaccine,Monovalent Influenza Vaccines,Quadrivalent Influenza Vaccine,Trivalent Influenza Vaccine,Trivalent Live Attenuated Influenza Vaccine,Universal Flu Vaccines,Universal Influenza Vaccines,Flu Vaccine, Universal,High Dose Trivalent Influenza Vaccine,Influenza Vaccine, Monovalent,Influenza Vaccine, Quadrivalent,Influenza Vaccine, Trivalent,Influenza Vaccine, Universal,Intranasal Live Attenuated Influenza Vaccine,Vaccine, Flu,Vaccine, Influenza,Vaccine, Influenza Virus,Vaccine, Influenzavirus,Vaccine, LAIV,Vaccine, Monovalent Influenza,Vaccine, Quadrivalent Influenza,Vaccine, Trivalent Influenza,Virus Vaccine, Influenza
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006385 Hemagglutination Inhibition Tests Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination. Hemagglutination Inhibition Test,Inhibition Test, Hemagglutination,Inhibition Tests, Hemagglutination,Test, Hemagglutination Inhibition,Tests, Hemagglutination Inhibition
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D012426 Russia A country located in north Asia bordering the Arctic Ocean, extending from Europe (the portion west of the Urals) to the North Pacific Ocean. The capital is Moscow. Russian S.F.S.R.,Russian Federation (Europe),Russian SFSR
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species

Related Publications

A N Slepushkin, and T K Bobyleva, and A E Russina, and B S Vitkina, and N S Ellengorn
[Effectiveness of vaccination against influenza].
September 1954, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
A N Slepushkin, and T K Bobyleva, and A E Russina, and B S Vitkina, and N S Ellengorn
[Effectiveness evaluation of the influenza vaccination].
July 1971, Das Deutsche Gesundheitswesen,
A N Slepushkin, and T K Bobyleva, and A E Russina, and B S Vitkina, and N S Ellengorn
[Effectiveness of interepidemic vaccination against influenza].
January 1968, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-hygienische Bakteriologie, Virusforschung und Parasitologie. Originale,
A N Slepushkin, and T K Bobyleva, and A E Russina, and B S Vitkina, and N S Ellengorn
[Effectiveness of mass vaccination against influenza].
September 1954, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
A N Slepushkin, and T K Bobyleva, and A E Russina, and B S Vitkina, and N S Ellengorn
Evaluation of the effectiveness of large-scale vaccination against influenza in the USSR.
January 1967, Bulletin of the World Health Organization,
A N Slepushkin, and T K Bobyleva, and A E Russina, and B S Vitkina, and N S Ellengorn
[Effectiveness of vaccination against influenza in the elderly].
December 1995, Ugeskrift for laeger,
A N Slepushkin, and T K Bobyleva, and A E Russina, and B S Vitkina, and N S Ellengorn
[Problem of effectiveness of vaccination against influenza].
January 1956, Voprosy virusologii,
A N Slepushkin, and T K Bobyleva, and A E Russina, and B S Vitkina, and N S Ellengorn
Evaluation of the effectiveness of anti-influenza vaccination.
October 1958, Canadian Medical Association journal,
A N Slepushkin, and T K Bobyleva, and A E Russina, and B S Vitkina, and N S Ellengorn
Plan for the evaluation of vaccination against influenza.
August 1951, American journal of public health and the nation's health,
A N Slepushkin, and T K Bobyleva, and A E Russina, and B S Vitkina, and N S Ellengorn
[Attempted evaluation of the effectiveness of anti-influenza vaccination].
November 1971, Les Cahiers de medecine,
Copied contents to your clipboard!